When equal daily doses of venlafaxine were administered as either an immediate release tablet or the extended-release capsule, the exposure to both venlafaxine and ODV was similar for the two treatments, and the fluctuation in plasma concentratio...
Maintenance of healing: 150 mg PO q12hr Hypersecretory Conditions 150 mg PO q12hr; up to 6 g/day used Parenteral: 50 mg (2 mL) IM or intermittent IV bolus or infusion q6-8hr; not to exceed 400 mg/day; alternatively, 6.25 mg/hr continuous infusion Dosing considerations More frequent ...